Your browser doesn't support javascript.
loading
Predicting Durable Responses to Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Using a Multi-Feature Model.
Wang, Lei; Zhang, Hongbing; Pan, Chaohu; Yi, Jian; Cui, Xiaoli; Li, Na; Wang, Jiaqian; Gao, Zhibo; Wu, Dongfang; Chen, Jun; Jiang, Jizong; Chu, Qian.
Afiliación
  • Wang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang H; Department of Lung Cancer Surgery, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Pan C; Department of Medicine, YuceBio Technology Co., Ltd, Shenzhen, China.
  • Yi J; The First Affiliated Hospital, Jinan University, Guangzhou, China.
  • Cui X; Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Jinan University, Zhuhai, China.
  • Li N; The Biomedical Translational Research Institute, Faculty of Medical Science, Jinan University, Guangzhou, China.
  • Wang J; Department of Medicine, YuceBio Technology Co., Ltd, Shenzhen, China.
  • Gao Z; Department of Medicine, YuceBio Technology Co., Ltd, Shenzhen, China.
  • Wu D; Department of Medicine, YuceBio Technology Co., Ltd, Shenzhen, China.
  • Chen J; Department of Medicine, YuceBio Technology Co., Ltd, Shenzhen, China.
  • Jiang J; Department of Medicine, YuceBio Technology Co., Ltd, Shenzhen, China.
  • Chu Q; Department of Medicine, YuceBio Technology Co., Ltd, Shenzhen, China.
Front Immunol ; 13: 829634, 2022.
Article en En | MEDLINE | ID: mdl-35529874

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China